Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
227.8 CHF | +1.20% | +4.26% | -6.83% |
07:27am | Lonza Affirms FY24 Sales Outlook, Raises Mid-term Growth Guidance | MT |
May. 10 | Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.83% | 203B | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU